Facebook Tracking Image

National Comprehensive Cancer Network

Interactive CME

Educational Events & Programs


NCCN Academy Scottsdale, AZ October 29, 2019


NCCN Academy Date >October 29, 2019 > Enroll Today!

NEW LOCATION > The Phoenician / Scottsdale, Arizona

Enroll Now




NCCN Academy for Excellence & Leadership in Oncology™: School of Pharmaceutical & Biotech Business will take place on Tuesday, October 29 at The Phoenician in Scottsdale, Arizona.

This program will give pharmaceutical and biotechnology professionals the rare opportunity to view the oncology space, its future and its current operational issues from the provider, advocacy, and payer perspectives. Participants will improve their working knowledge of key business, policy, coverage, reimbursement, informational, and operational issues in oncology while gathering valuable insights into developing effective strategies for navigating the cancer care ecosystem. Through this interactive program, pharmaceutical and biotech professionals will learn from key stakeholders what they view to be the most pressing issues in oncology today and how to apply this knowledge to create mutually-successful working relationships.

Professionals from advocacy, clinical research, marketing, market access, medical affairs, policy and government affairs, sales, and other business areas will better be able to serve their customers with improved knowledge of real-world oncology issues after completion of this program.

Please check back often for additional updates regarding this program. If you have any questions, please contact Elyse Desjardins, MBA, Business Development Program Manager.


Clifford Goodman

Clifford Goodman, PhD
Senior Vice President
The Lewin Group




11:10 - 11:50 AM

Lunch and Registration

12:00 – 12:05 PM


C. Lyn Fitzgerald, MJ
Senior Vice President, U.S. & Global Development
National Comprehensive Cancer Network

12:10 – 1:40 PM

Module I:
The Employers Role in Ensuring Access to Quality

Cancer Care

Joseph Alvarnas, MD
Vice President of Government Affairs & Senior Medical Director for Employer Strategy
Associate Clinical Professor, Department of Hematology &
Hematopoietic Cell Transplantation
City of Hope National Medical Center

K. Andrew Crighton, MD, CPE
Former, Vice President & Chief Medical Officer,
Global Health Organization

Emma Hoo
Pacific Business Group on Health

Jason Parrott
Senior Manager, Global Healthcare & Well Being Strategy

Michael J. Valenta
Executive Director, Market Access
Merck & Co. Inc.

1:40 – 1:50 PM


1:55 – 3:20 PM

Module II:
Meet the NCCN Guidelines® Panel Experts     

Robert W. Carlson, MD
Chief Executive Officer
National Comprehensive Cancer Network

Steven J. Isakoff, MD, PhD
Associate Director for Breast Cancer Clinical Research
Dana-Farber/Brigham and Women’s Cancer Center I Massachusetts
General Hospital Cancer Center

Member, NCCN Guidelines for Breast Cancer Panel        
Martin Tallman, MD
Chief, Leukemia Service
Memorial Sloan Kettering Cancer Center
Chair, NCCN Guidelines for Acute Myeloid Leukemia Panel

Margaret A. Tempero, MD
Director, UCSF Pancreas Center
Rombauer Family Distinguished Professorship in Pancreas Cancer Clinical and Translational Science
Professor of Medicine, UCSF Department of Medicine
UCSF Helen Diller Family Comprehensive Caner Center
Journal of the National Comprehensive Cancer Network, JNCCN
NCCN Guidelines for Pancreatic Adenocarcinoma Panel

Emily Wyse
Project Coordinator II, Radiation Oncology
Fred Hutchinson Cancer Research Center/
Seattle Cancer Care Alliance

Member, NCCN Guidelines for Cervical Cancer Panel
Member, NCCN Guidelines for Uterine Neoplasms

3:20 – 3:30 PM


3:35 – 5:00 PM

Module III:
A View Across the Oncology Ecosystem: Policy, Access and Strategic Priorities for Advancing Patient-Centered Care

Alan Balch, PhD
Chief Executive Officer
National Patient Advocate Foundation

Sarah F. Duggan Goldstein, MPH
Senior Clinical Consultant
Blue Distinction, Blue Cross Blue Shield Association

Kjel Johnson, PharmD
Vice President, Specialty Strategy and Client Solutions
CVS Health

Michael Kolodziej, MD
Vice President and Chief Innovation Officer

Albert L Krause, PhD
Global Regulatory Portfolio Lead
Women’s & Gastrointestinal Cancers

Diana Verrilli, MPH
Senior Vice President, Strategy and Practice Solutions

Ronald S. Walters, MD, MBA, MHA, MS
Associate Head for the Institute for Cancer Care Innovation Professor, Breast Medical Oncology
The University of Texas MD Anderson Cancer Center

5:00 PM

Closing Remarks

Gary Weyhmuller, MBA, SPHR
Executive Vice President/Chief Operating Officer
National Comprehensive Cancer Network

Customize your own NCCN Academy curriculum.

NCCN offers the unique opportunity to customize an NCCN Academy curriculum that best aligns with your organization's particular needs and interests

Approximately 97 percent of recent NCCN Academy attendees say they would attend an NCCN Academy program again or recommend that colleagues attend.